Difference between revisions of "Paliperidone ER-Risperidone"
From Psychiatrienet
(Created page with "<big><span style="color:#ff0000"> * This switch is intended for paliperidone long acting (Xeplion®, 30 days) </span></big> {{Drugswitch | from = Paliperidone LA | to = Risp...") |
|||
| Line 3: | Line 3: | ||
{{Drugswitch | {{Drugswitch | ||
| from = Paliperidone LA | | from = Paliperidone LA | ||
| − | | to = Risperidone | + | | to = Risperidone<ref> A. Risselada, Switchen van en naar depotantipsychotica - een update; Psyfar, june 2022 nummer 2 </ref> |
| stop = {{Lastinjection}} | | stop = {{Lastinjection}} | ||
| − | | start = {{ | + | | start = {{StartOral afterDepot} |
| info = {{caveQT}} | | info = {{caveQT}} | ||
| − | + | * the T<sub>1/2</sub> of a monthly paliperidon depot is approximately '''25-49 days'''.<ref> KNMP Kennisbank, informatorium medicamentorum: Paliperidon</ref> | |
}} | }} | ||
Revision as of 14:21, 20 February 2025
* This switch is intended for paliperidone long acting (Xeplion®, 30 days)
{{Drugswitch | from = Paliperidone LA | to = Risperidone[1] | stop =
- Day 1: Last depot injection
| start = {{StartOral afterDepot} | info =
- During this switch you could monitor ECG, especially in patients prone to QT-conduction problems.
- There is a possibility of QT interval prolongation.[2]
- the T1/2 of a monthly paliperidon depot is approximately 25-49 days.[3]
}}
- ↑ A. Risselada, Switchen van en naar depotantipsychotica - een update; Psyfar, june 2022 nummer 2
- ↑ Stöllberger C, Huber JO, Finsterer J, Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005 Sep;20(5):243-51.
- ↑ KNMP Kennisbank, informatorium medicamentorum: Paliperidon
